Unique ID issued by UMIN | UMIN000024533 |
---|---|
Receipt number | R000028238 |
Scientific Title | Intensity and timing of exercise for controling postprandial hyperglycemia in patients with type 2 diabetes |
Date of disclosure of the study information | 2016/10/24 |
Last modified on | 2016/10/24 09:20:07 |
Intensity and timing of exercise for controling postprandial hyperglycemia in patients with type 2 diabetes
Exercise protcol for postprandial hyperglycemia
Intensity and timing of exercise for controling postprandial hyperglycemia in patients with type 2 diabetes
Exercise protcol for postprandial hyperglycemia
Japan |
Type 2 Diabetes
Medicine in general | Endocrinology and Metabolism | Adult |
Others
YES
The inhibitory effect of postprandial blood glucose level due to the difference in the exercise intensity for type 2 diabetes.
Safety,Efficacy
Comparison the area under the concentration-time curve of blood glucose concentration for 4 hours between exercise intensity.
1. Correlation between the blood glucose value AUC for 4 hours after lunch and selenoprotein P concentration , general findings , and laboratory values.
2. Comparison between the blood glucose value AUC for 4 hours after lunch and exercise start time.
3. Relation between the blood glucose value AUC for 4 hours after lunch and gene expression.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Day1: a 60-minute bicycle ergometer exercise at 25% HRMax from postprandial 1 hour
Day2: a 30-minute bicycle ergometer exercise at 50% HRMax from postprandial 1 hour
Day3: a 20-minute bicycle ergometer exercise at 75% HRMax from postprandial 1 hour
Day4: a 30-minute bicycle ergometer exercise at 50% HRMax from postprandial 2 hour
Day5: no exercise
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1. Type 2 Diabetes
2. Patients with exercise therapy has been formulated in diabetes education hospitalization.
Poorly controlled hypertension
None type 2 diabetes
Insulin treatment
B2 blocker use patient
Positive anti-GAD antibodies
Kidny disease(stage 3 or later)
Pregnant or lactating women
Inability to participate in the study as assessed by the investigators.
20
1st name | |
Middle name | |
Last name | Toshinari Takamura |
Kanazawa University Graduate School of Medical Sciences
Comprehensive Metabology, Kanazawa University Graduate School of Medical Sciences
13-1 Takara-machi, Kanazawa, Ishikawa
076-265-2234
ttakamura@m-kanazawa.jp
1st name | |
Middle name | |
Last name | Yumie Takeshita |
Kanazawa university hospital
Department of Disease Control and Homeostasis
13-1 Takara-machi, Kanazawa, Ishikawa
076-265-2234
takeshita@m-kanazawa.jp
Kanazawa university hospital
Department of Disease Control and Homeostasis
Kanazawa university hospital
Department of Disease Control and Homeostasis
Self funding
YES
2070-1
Kanazawa university
金沢大学附属病院 恒常性制御学
小松ソフィア病院 内分泌代謝内科
2016 | Year | 10 | Month | 24 | Day |
Unpublished
Open public recruiting
2016 | Year | 02 | Month | 27 | Day |
2016 | Year | 02 | Month | 27 | Day |
2016 | Year | 10 | Month | 24 | Day |
2016 | Year | 10 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028238
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |